Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease

The presence of an abnormally increased pulmonary blood pressure worsens the prognosis of patients with interstitial pulmonary disease.

The aim of this study is to estimate the frequency of an increased blood pressure in the lungs among patient with interstitial pulmonary disease, and to evaluate the use of different biomarkers in diagnosis of the condition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Interstitial Lung Disease Biomarkers Cardiovascular Diseases Hypertension Hypertension, Pulmonary Lung Diseases Lung Diseases, Interstitial Pulmonary Hypertension Respiratory Tract Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Pulmonary Diseases, Århus Sygehus, Aarhus, Denmark

About this study

The presence of increased pulmonary blood pressure is established by echocardiography and confirmed by right heart catheterization.

The ability of NT-proBNP, vWf, troponin-t, D-dimer and exhaled NO to predict the presence of increased pressure in the pulmonary circulation is evaluated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Interstitial pulmonary disease

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Registry information

Official study title

The Prevalence of Pulmonary Hypertension and the Significance of Different Biomarkers in Chronic Interstitial Lung Disease

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Jan 12, 2009
Registry last updated: Sep 18, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed